Life Science Nation Newsletter | August 23, 2018 | Issue 280

  The LSN Story   |   Investor Platform   |   Company Platform   |   RESI Conference   |   Fundraising Consulting
  Life Science Investor Mandates  (Aug. 16 - Aug. 22 )
Seeks to Invest in All Sectors of Life Sciences, with Capacity for $250M Per Deal
Looks for IND-Ready Drug Assets Across Areas of Unmet Medical Need to Develop Through Phase II PoC
Most Interested in Investing in Early-Stage Diagnostics and Research Tools with High Growth Potential
Seeks R&D and Venture Funding Opportunities in Medtech and Diagnostics Companies, with Strong Preference for Cardiovascular & Regenerative Indications
LSN Services
LSN Videos
LSN Media Partners
By Nono Hu, Director of Marketing, LSN

The First Coast Innovator's Gathering is a new element of RESI Boston. Tech hubs and their constituents based in the "First Coast" of life sciences in the US Northeast will gather together at RESI for the first time to get on the radar screens of potential global investors and strategic partners.

First Coast Innovation Challenge invited all eligible tech hub members from DC to Boston to apply for an opportunity to pitch to a panel of early stage investors. The 8 finalists were selected by LSN's Expert System and scientific review team to present their technology through a 7-minute pitch. Investors will provide feedback and questions to the pitching CEOs.  

The competition is moderated by Dennis Ford, CEO & Founder, Life Science Nation, and the  participating investors are:
  • Elona Baum, Managing Director, DEFTA Partners
  • Tim Xiao, Principal, Delos Capital
  • Allan Daisley, Managing Director, Startupbootcamp Digital Health Miami
  • Qiong Ye, Investment Manager, Yonghua Capital
  • Dean Slack, Pharmaceutical Industry exec with New Product Planning, BD, Commercialization & Banking
  • Bert Lederer, Executive Director, Cherrystone Angel Group
First Coast Innovation Challenge Finalists

By Dennis Ford, Founder & CEO, Life Science Nation; Creator of RESI Conference Series

In November 2017, RESI came to New York for the first time and gathered together investors from all over the world to meet scientist-entrepreneurs from the rising life science hub in the city. With hundreds of partnering meetings based on fit, RESI NYC allowed these entrepreneurs to start dialogues with global investors drawn from LSN's established network.  

RESI NYC will feature a full day of partnering, panel and workshop content, networking and more. Startups from the biotech, medtech, diagnostics and digital health verticals are now welcome to register for RESI NYC to join the global investor dialogue. We hope you will join us again there.

By Lucy Parkinson, VP of Investor Research, LSN

The Boston area is known worldwide as a hub for early stage biotech companies, and this year's RESI Boston event will also feature young biotech spinouts from tech hubs and universities from all around the biotech 'First Coast' in the US Northeast. To commercialize their discoveries, these young companies will need to access capital. 

This panel of Early Stage Therapeutic Investors aims to bring a diverse group of experts and senior decision making staff from VCs, corporate pharma, and other investor types together to discuss topics such as:
  • How they make decisions
  • What can startups do to be more attractive?
  • Areas of high need
  • Overcrowded areas
  • Common mistakes/red flags
The participants are:
  • Kuldeep Neote, Senior Director - New Ventures, Johnson & Johnson Innovation
  • Scott Weiner, Partner, Pappas Ventures
  • Bibhash Mukhopadhyay, Principal, New Enterprise Associates
  • Marta New, Partner, Agent Capital
  • Imran Babar, Chief Business Officer, Cydan

Created & Produced by